Photo from open sources
American specialists, using the help of colleagues from Britain, created a medication for the treatment of the so-called “vampire diseases.”
It is an erythropoietic protoporphyria. Don’t be scared people with this disease they don’t drink blood and calmly reflected in the mirrors, however, their skin is extremely sensitive to sunlight. Having been in the sun for only a couple of minutes, a person with such an ailment can get very severe burns. The disease is considered one of the rarest: there are no more than ten on the planet thousand people who are not able to be in the natural light.
Scientists conducted a series of experiments, finding out that implantation drug agent to a person with erythropoietic protoporphyria allows the patient to stay in the sun much longer time. As an agent, specialists used afamelanotide – a substance that darkens human skin. If every two months implant the patient with an implant the size of a rice grain, then his cells skin will begin to produce the melanin needed for resistance solar radiation.
Dosage has already been successfully tested in adults volunteers. Now scientists have to find the optimal dose medication for children. After all, erythropoietic protoporphyria is a hereditary disease and often manifests itself from the earliest years.
An afamelanotide implant has been reported to allow the patient be in the sun until sixty-nine hours, and that, of course same, much longer than any person in during the day.
The sun
